Insider Trading History of Hazen Samuel N

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hazen Samuel N since 2015. This trader's CIK number is 1216838. At the time of last reporting, Hazen Samuel N was the CEO of Hca Healthcare, Inc.. (stock ticker symbol HCA). Also see all insider trading activities at Hca Healthcare, Inc..


Yearly summary of insider trading at Hca Healthcare, Inc. (HCA) by Hazen Samuel N

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 HCA 0 $0 0 $0 58,050 $4,039,119
2023 HCA 0 $0 0 $0 59,000 $4,068,639
2022 HCA 0 $0 0 $0 6,011 $0
2021 HCA 0 $0 50,000 $12,587,400 152,625 $7,321,421
2020 HCA 0 $0 121,875 $16,556,962 557,125 $13,472,396
2019 HCA 0 $0 0 $0 3,535 $0
2018 HCA 0 $0 56,000 $5,626,208 428,192 $7,529,847
2017 HCA 0 $0 0 $0 2,391 $0
2015 HCA 0 $0 180,000 $14,400,000 360,000 $2,993,040


Insider trading of Hca Healthcare, Inc. (HCA) by Hazen Samuel N

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-10-31 HCA Option Ex 58,050 69.58 4,039,119
2023-02-03 HCA Option Ex 59,000 68.96 4,068,639
2022-02-18 HCA Option Ex 6,011 .00 0
2021-11-02 HCA Sale 50,000 251.75 12,587,400
2021-10-29 HCA Option Ex 152,625 47.97 7,321,421
2020-11-03 HCA Option Ex 557,125 24.18 13,472,396
2020-11-03 HCA Sale 121,875 135.85 16,556,962
2019-02-25 HCA Option Ex 3,535 .00 0
2018-02-25 HCA Option Ex 5,926 .00 0
2018-01-31 HCA Option Ex 422,266 17.83 7,529,847
2018-01-31 HCA Sale 56,000 100.47 5,626,208
2017-02-25 HCA Option Ex 2,391 .00 0
2015-04-15 HCA Option Ex 360,000 8.31 2,993,040
2015-04-15 HCA Sale 180,000 80.00 14,400,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hazen Samuel N (CEO of Hca Healthcare, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.